We are live on ! Find out more
ACM

Anfield Capital Management Portfolio holdings

AUM $363M
1-Year Est. Return 24.08%
This Fund
S&P 500
This Quarter Est. Return
-10.36%
1 Year Est. Return
+24.08%
3 Year Est. Return
+65.24%
5 Year Est. Return
+71.54%
10 Year Est. Return
AUM
$221M
AUM Growth
-$52.5M
Cap. Flow
-$18.4M
Cap. Flow %
-8.32%
Top 10 Hldgs %
57.29%
Holding
108
New
13
Increased
54
Reduced
20
Closed
16
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
76
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$151K 0.07%
1,887
+445
+31% +$42.1K
INCY icon
77
Incyte
INCY
$24.4B
$146K 0.07%
1,916
+478
+33% +$36.3K
CHE icon
78
Chemed
CHE
$7.22B
$75K 0.03%
159
+53
+50% +$25.9K
SDIV icon
79
Global X SuperDividend ETF
SDIV
$1.21B
$74K 0.03%
2,669
+2,062
+340% +$64.3K
EXEL icon
80
Exelixis
EXEL
$13.4B
$72K 0.03%
3,438
+1,219
+55% +$25.1K
BKT icon
81
BlackRock Income Trust
BKT
$341M
$53K 0.02%
3,904
+86
+2% +$1.21K
HALO icon
82
Halozyme
HALO
$12.2B
$48K 0.02%
1,093
+156
+17% +$6.75K
XLF icon
83
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$40K 0.02%
1,273
-648,985
-100% -$22.4M
XLY icon
84
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$33K 0.01%
480
-273,028
-100% -$21.5M
CPRX
85
DELISTED
Catalyst Pharmaceutical
CPRX
$28K 0.01%
3,983
+380
+11% +$2.79K
CRSP icon
86
CRISPR Therapeutics
CRSP
$5.17B
$23K 0.01%
373
+72
+24% +$4.23K
AMPH icon
87
Amphastar Pharmaceuticals
AMPH
$916M
$21K 0.01%
593
+84
+17% +$3K
INVA icon
88
Innoviva
INVA
$1.48B
$20K 0.01%
1,350
+144
+12% +$2.36K
IRWD icon
89
Ironwood Pharmaceuticals
IRWD
$714M
$20K 0.01%
1,741
+232
+15% +$2.73K
VIR icon
90
Vir Biotechnology
VIR
$1.49B
$19K 0.01%
762
+112
+17% +$2.62K
EBS icon
91
Emergent Biosolutions
EBS
$248M
$15K 0.01%
490
+72
+17% +$2.46K
QURE icon
92
uniQure
QURE
$3.22B
$13K 0.01%
710
+164
+30% +$2.61K
AFIF icon
93
Anfield Universal Fixed Income ETF
AFIF
$228M
-419,705
Closed -$3.88M
AIG icon
94
American International
AIG
$41.3B
-3,241
Closed -$203K
BX icon
95
Blackstone
BX
$110B
-24,846
Closed -$3.15M
EXPE icon
96
Expedia Group
EXPE
$37.3B
-2,200
Closed -$430K
HCA icon
97
HCA Healthcare
HCA
$89.5B
-1,500
Closed -$376K
HOMZ icon
98
Hoya Capital Housing ETF
HOMZ
$36.7M
-47,177
Closed -$1.82M
IEUR icon
99
iShares Core MSCI Europe ETF
IEUR
$9.16B
-7,549
Closed -$403K
NURE icon
100
Nuveen Short-Term REIT ETF
NURE
$35.5M
-54,521
Closed -$2.13M

Similar funds

Anfield Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Anfield Capital Management held 108 positions worth $221M, down 19% from $273M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Anfield Capital Management withdrew a net $18.4M in Q2 2022, closing 16 positions and reducing 20 holdings. Its most notable exit was Anfield Universal Fixed Income ETF, an estimated $3.88M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 2% of assets, up from 1.6% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Anfield Capital Management opened a new position in State Street Consumer Staples Select Sector SPDR ETF worth $18.8M.

  • Anfield Capital Management's largest Q2 2022 buy was State Street Consumer Staples Select Sector SPDR ETF: 259,940 shares worth $18.8M.
  • Anfield Capital Management added most to State Street Health Care Select Sector SPDR ETF in Q2 2022, an estimated $7.33M increase.
  • Anfield Capital Management's biggest Q2 2022 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $22.4M.
  • Anfield Capital Management fully exited Anfield Universal Fixed Income ETF in Q2 2022, selling an estimated $3.88M.
  • Anfield Capital Management's ten largest holdings make up 57% of its $221M portfolio in Q2 2022.
  • Anfield Capital Management opened 13 new positions and closed 16 in Q2 2022.
  • Anfield Capital Management's portfolio value fell 19% quarter-over-quarter to $221M.

Based on Anfield Capital Management's 13F filing for Q2 2022, filed 9 Aug 2022.